US Patent Issued to Pinchas Zaltzman on Sept. 15 for "Pharmaceutical compositions for relief of COVID-19 symptoms and methods of producing and using them" (Israeli Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,183, issued on Sept. 15, was assigned to Pinchas Zaltzman (Bnei Brak, Israel).

"Pharmaceutical compositions for relief of COVID-19 symptoms and methods of producing and using them" was invented by Pinchas Zaltzman (Bnei Brak, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition including: (a) a tetracycline family antibiotic, sodium tetraborate decahydrate, Calendula oil, Propolis, Echinacea sp. tincture; and (b) a liquid carrier comprising glycerin and ethanol."

The patent was filed on April 27, 2021, under Application No. 17/921,474.

*For further information, including images, charts and tables, please visit: http:...